Protein kinase Cδ expression in breast cancer as measured by real-time PCR, western blotting and ELISA

British Journal of Cancer

Volumn 99, Issue 10, 2008, Pages 1644-1650

  McKiernan, E ^a,b   O'Brien, K ^a,b   Grebenchtchikov, N ^c   Geurts Moespot, A ^c   Sieuwerts, A M ^d   Martens, J W M ^d   Magdolen, V ^e   Evoy, D ^b   McDermott, E ^b   Crown, J ^a   Sweep, F C G J ^c   Duffy, M J ^a,b  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Breast cancer; Protein kinase C

Indexed keywords

ESTROGEN RECEPTOR; MESSENGER RNA; PROTEIN KINASE C DELTA;

ADULT; ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER SURVIVAL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; MOLECULAR WEIGHT; OVERALL SURVIVAL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; BIOSYNTHESIS; BREAST TUMOR; DISEASE COURSE; FEMALE; GENETICS; METABOLISM; MIDDLE AGED; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL;

BLOTTING, WESTERN; BREAST NEOPLASMS; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROTEIN KINASE C-DELTA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SURVIVAL ANALYSIS;

EID: 55949118472     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6604728     Document Type: Article

References (14)

1. Assender JW, Gee JMW, Lewis I, Ellis O, Robertson JFR, Nicholson RI (2007) Protein kinase C isoform expression as a predictor of disease outcome on endocrine therapy in breast cancer. J Clin Pathol 60: 1216-1221
2. Branscombe MT, Jones PA (2007) DNA methylation: the nuts and bolts of repression. J Cell Physiol 213: 384-390
3. Duffy MJ (2006) Estrogen receptors: role in breast cancer. Crit Rev Clin Lab Sci 43: 325-347
4. Emoto Y, Manome Y, Meinhardt G, Kisaki H, Kharbanda S, Robertson M, Ghayur T, Wong WW, Kamen R, Weichselbaum R, Kufe D (1995) Proteolytic activation of protein kinase C δ by ICE-like protease in apoptotic cells. EMBO J 14: 6148-6156
5. Grebenchtchikov N, Sweep CGJ, Geurts-Moespot A, Piffanelli A, Foekens JA, Benraad TJ (2002) An ELISA avoiding interference by heterophilic antibodies in the measurement of components of the plasminogen activation system in blood. J Immunol Methods 268: 219-231
6. Grebenschikov N, Geurts-Moespot A, De Witte H, Heuvel J, Leake R, Sweep F, Benraad T (1997) A sensitive and robust assay for urokinase and tissue-type plasminogen activators (uPA and tPA) and their inhibitor type 1 (PAI-1) in breast tumor cytosols. Int J Biol Markers 12: 6-14
7. Griner EM, Kazanietz MG (2007) Protein kinase C and other diacylglycerol effectors in cancer. Nat Rev Cancer 7: 281-294
8. Jackson DN, Foster DA (2004) The enigmatic protein kinase Cδ: complex roles in cell proliferation and survival. FASEB J 18: 627-636
9. Khoshnoud MR, Fornander T, Johansson H, Rutqvist L-R (2008) Long-term pattern of disease recurrence among patients with early-stage breast cancer according to estrogen receptor status and use of adjuvant tamoxifen. Breast Cancer Res Treat 107: 71-78
10. Kiley SC, Clark KJ, Goodnough M, Welch DR, Jaken S (1999) Protein kinase C delta involvement in mammary tumor cell metastasis. Cancer Res 59: 3230-3238
11. Martens JWM, Nimmrich I, Koenig T, Look MP, Harbeck N, Model F, Kluth A, Bolt-de Vries J, Sieuwerts AM, Portengen H, Meijer-Van Gelder ME, Piepenbrock C, Olek A, Höfler H, Kiechle M, Klijn JGM, Schmitt M, Maier S, Foekens JA (2005) Association of DNA methylation of phosphoserine aminotransferase with response to endocrine therapy in patients with recurrent breast cancer. Cancer Res 65: 4101-4107
12. Nabha SM, Glaros S, Hong M, Lykkesfeldt AE, Schiff R, Osborne K, Reddy KB (2005) Upregulation of PKC-delta contributes to antiestrogen resistance in mammary tumor cells. Oncogene 24: 3166-3176
13. Sieuwerts AM, Meijer-van Gelder ME, Timmermans M, Trapman AMAC, Rodriguez Garcia R, Arnold M, Goedheer AJW, Portengen H, Klijn JGM, Foekens JA (2005) How ADAM-9 and ADAM-11 differentially from estrogen receptor predict response to tamoxifen treatment in patients with recurrent breast cancer: a retrospective study. Clin Cancer Res 11: 7311-7321
14. Soerjomataram I, Louwman MWJ, Ribot JG, Roukema JA, Coebergh JWW (2008) An overview of prognostic factors for long-term survivors of breast cancer. Breast Cancer Res Treat 107: 309-330